CD4-binding site alterations in CCR5-using HIV-1 envelopes influencing gp120-CD4 interactions and fusogenicity

Jasminka Sterjovski1, Melissa J Churchill, Michael Roche

  • 1Center for Virology, Burnet Institute, Melbourne, Victoria, Australia.

Virology
|January 11, 2011
PubMed

Insights

Alterations in the HIV gp120 CD4-binding site influence viral function. The V5 loop may change the CD4-binding site conformation, enhancing gp120-CD4 interactions and viral fusion.

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • Alterations in the CD4-binding site (CD4bs) of gp120 are linked to distinct pathophysiological phenotypes in CCR5-using (R5) HIV-1 strains.
  • The structural basis for these CD4bs alterations and their functional consequences remains largely unexplored.

Purpose of the Study:

  • To investigate potential structural alterations within the gp120 CD4bs of R5 HIV-1 strains.
  • To elucidate how these structural changes influence envelope (Env) protein function, including CD4 binding and viral fusion.

Main Methods:

  • Characterization of 16 functionally diverse R5 HIV-1 Env clones.
  • Analysis of three-dimensional gp120 structural models.
  • Correlation of structural features with gp120-CD4 binding, CD4 dependence, and Env fusogenicity.

Main Results:

  • Increased gp120-CD4 binding correlated with enhanced fusogenicity and reduced CD4 dependence.
  • Specific CD4bs variants (D279 and N362) were associated with reduced CD4 dependence.
  • A wider CD4bs cavity, influenced by the V5 loop and V1V2 stem, correlated with increased gp120-CD4 binding and fusogenicity.

Conclusions:

  • The gp120 V5 loop plays a role in modulating CD4bs conformation.
  • Alterations in the V5 loop can enhance gp120-CD4 interactions and Env fusogenicity, contributing to R5 HIV-1 pathogenesis.

Related Concept Videos